Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1998-7-1
pubmed:abstractText
Mouse cytotoxic T lymphocytes (CTL) reactive with a H-2Db-presented 9-mer peptide of the human papillomavirus type 16 protein E7(49-57) (RAHYNIVTF) were generated from the spleen cells of wild-type C57BL/6 (B6) or B6 perforin-deficient (B6.P0) mice. CD8(+) B6 CTL displayed peptide-specific perforin- and Fas-mediated lysis of E7-transfected mouse RMA lymphoma cells (RMA-E7), while CD8(+) CTL from B6.P0 mice lysed RMA-E7 cells via Fas ligand (FasL) exclusively. Rapid and efficient lysis of syngeneic bystander B6 blasts or RMA cells by either B6 or B6.P0 Ag-activated CTL was mediated by a FasL-Fas mechanism. Fas-resistant bystanders were not lysed, nor were allogeneic Fas-sensitive C3H/HeJ (H-2(k)) or BALB/c (H-2(d)) bystander blasts. Interestingly, however, phorbol myristate acetate-ionomycin preactivation of B6.P0 effectors enabled lysis of allogeneic H-2(k) and H-2(d) bystanders even in the absence of antigenic stimulation. Lysis of syngeneic bystander cells was always FasL-Fas dependent and required effector-bystander contact and, in particular, an interaction between CTL LFA-1 and bystander ICAM-1. Thus, in the context of major histocompatibility complex class I molecule-peptide ligation of the T-cell receptors of CD8(+) CTL, neighboring bystander cells that are syngeneic and Fas sensitive and express the adhesion molecule ICAM-1 are potential targets of CTL attack.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-1716919, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-1910674, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-1944559, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-2787386, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-2953785, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-3500224, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-3877776, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-3904772, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-6979720, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7481562, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7509084, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7518614, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7520535, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7526382, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7528780, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7530335, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7530763, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7533326, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7533644, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7566090, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7576051, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7603571, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7678113, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7689176, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7734049, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-7972104, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-8104338, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-8137429, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-8164737, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-8816403, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-8861915, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-8920866, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-8958289, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-9164947, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-9190918, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-9190927, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-9195941, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-9233613, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-9300693, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-9314566, http://linkedlifedata.com/resource/pubmed/commentcorrection/9621057-9378969
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
72
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5948-54
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Fas ligand-mediated lysis of self bystander targets by human papillomavirus-specific CD8+ cytotoxic T lymphocytes.
pubmed:affiliation
Cellular Cytotoxicity Laboratory, The Austin Research Institute, Heidelberg 3084, Victoria, Australia. m.smyth@ari.unimelb.edu.au
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't